Topic: Leadership & Team Building in the Life Sciences with Fereydoun Firouz
Please join us for the Life Science & Healthcare Fireside Founder Chat with Fereydoun Firouz, former CEO & President of EMD Serono. Fereydoun and I will be discussing how to build and lead winning teams and creating cultures of excellence in life science companies. We will also discuss the traits of strong leaders and how to a become an effective leader of a complex organization. We will talk about how to motivate and incentivize your team and learn about the importance of understanding what drives your teams members and employees. Lastly, we will discuss Fereydoun’s exciting career trajectory in life science industry and venture capital to gain insight into real worlds scenarios that foster great leaders.
Speaker Bio: Fereydoun Firouz is currently a Fellow of the HBS Advanced Leadership Initiative. Previously, Fereydoun was chairman and CEO of Stallergenes Greer, a UK-based biopharma company. Earlier he cofounded and was managing partner of Gurnet Point Capital, an investor in life sciences companies, and was managing director of Waypoint Capital, a Geneva-based family office, after a 20+ year career at biopharma company EMD Serono, which he ultimately led as president and CEO. Fereydoun serves on the presidential advisory council at the Berklee College of Music, and at the John F. Kennedy Library Foundation. He is also the producer of short films and documentaries focused on Persian art and culture. Fereydoun was a Red Cross delegate in Afghanistan during the Soviet-Afghan War, and a first lieutenant in the Swiss Army.
About Fireside Chats: Join us for the Health & Life Sciences Fireside Founder Chat, where you’ll get to hear directly from leaders from life science industry on lessons learned while building and running a companies. We will cover a variety of current topics relevant to H&LS founders including, multi-disciplinary team building & leadership, biotech innovation ecosystems, the impact of COVID on the life science industry, and current trends in life science venture capital & technology.
